These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice. Dirks M; Niessen LW; van Wijngaarden J; Koudstaal PJ; Franke CL; van Oostenbrugge RJ; Dippel DW; Int J Stroke; 2012 Jun; 7(4):289-92. PubMed ID: 22168317 [TBL] [Abstract][Full Text] [Related]
7. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment. Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714 [TBL] [Abstract][Full Text] [Related]
8. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C; N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770 [TBL] [Abstract][Full Text] [Related]
9. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. IST-3 collaborative group Lancet Neurol; 2013 Aug; 12(8):768-76. PubMed ID: 23791822 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162 [TBL] [Abstract][Full Text] [Related]
11. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Nakagawara J; Minematsu K; Okada Y; Tanahashi N; Nagahiro S; Mori E; Shinohara Y; Yamaguchi T; Stroke; 2010 Sep; 41(9):1984-9. PubMed ID: 20651262 [TBL] [Abstract][Full Text] [Related]
12. Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke. Huang X; Moreton FC; Kalladka D; Cheripelli BK; MacIsaac R; Tait RC; Muir KW Stroke; 2015 Dec; 46(12):3543-6. PubMed ID: 26514192 [TBL] [Abstract][Full Text] [Related]
13. Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review. Qureshi AI; Malik AA; Freese M; Thompson MJ; Khan AA; Suri MF Am J Emerg Med; 2015 Feb; 33(2):307.e1-4. PubMed ID: 25190550 [TBL] [Abstract][Full Text] [Related]
14. How Do Physicians Approach Intravenous Alteplase Treatment in Patients with Acute Ischemic Stroke Who Are Eligible for Intravenous Alteplase and Endovascular Therapy? Insights from UNMASK-EVT. Ospel JM; Kashani N; Fischer U; Menon BK; Almekhlafi M; Wilson AT; Foss MM; Saposnik G; Goyal M; Hill MD AJNR Am J Neuroradiol; 2020 Feb; 41(2):262-267. PubMed ID: 31974081 [TBL] [Abstract][Full Text] [Related]
15. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG; Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745 [TBL] [Abstract][Full Text] [Related]
16. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke. Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338 [TBL] [Abstract][Full Text] [Related]
17. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis. Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG; Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832 [TBL] [Abstract][Full Text] [Related]
18. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal. Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770 [TBL] [Abstract][Full Text] [Related]